| | | | | | | | |
| | | |
| | | | | | |
Cash flows from operating activities | | | | | | | | |
| | $ | (48,218 | ) | | $ | (8,937 | ) |
Adjustments to reconcile net loss to net cash provided by operating activities: | | | | | | | | |
Depreciation and amortization | | | 7,829 | | | | 9,747 | |
Amortization of debt issuance costs | | | 1,273 | | | | 1,292 | |
Amortization of prior hedge effectiveness | | | 3,076 | | | | 1,094 | |
| | | 48,584 | | | | 7,178 | |
Impairment of long-lived assets | | | 379 | | | | 555 | |
Impairment of investments | | | — | | | | 4,818 | |
| | | — | | | | 1,764 | |
| | | (1,612 | ) | | | (1,755 | ) |
Change in fair value of financial guarantee | | | (150 | ) | | | (1,000 | ) |
Change in fair value of derivative instruments | | | 28 | | | | 125 | |
Unrealized foreign exchange (gain) loss | | | (401 | ) | | | 2,498 | |
| | | 4 | | | | (5 | ) |
Changes in operating assets and liabilities, net of effects of disposal of business: | | | | | | | | |
| | | (2,308 | ) | | | (1,263 | ) |
Prepaid expenses and other current assets | | | (1,693 | ) | | | (160 | ) |
| | | (668 | ) | | | (186 | ) |
| | | 7,891 | | | | 13,478 | |
Accrued expenses and other liabilities | | | 3,195 | | | | (1,600 | ) |
| | | (276 | ) | | | 12 | |
| | | 23,763 | | | | 21,665 | |
| | | | | | | | |
Net cash provided by operating activities | | | 40,696 | | | | 49,320 | |
Cash flows from investing activities | | | | | | | | |
Purchase of property and equipment | | | (6,004 | ) | | | (4,491 | ) |
Sale of business, net of cash sold | | | — | | | | (1,175 | ) |
| | | | | | | | |
Net cash used in investing activities | | | (6,004 | ) | | | (5,666 | ) |
Cash flows from financing activities | | | | | | | | |
Repayment of capital lease obligations | | | (16 | ) | | | (16 | ) |
Repayment of 2018 Term Loan | | | (2,675 | ) | | | (2,675 | ) |
Proceeds from 2018 Revolving Facility | | | — | | | | 40,000 | |
Repayment of 2018 Revolving Facility | | | — | | | | (40,000 | ) |
| | | (1,332 | ) | | | (339 | ) |
Payment of initial public offering costs | | | (2,794 | ) | | | — | |
Payment of contingent consideration | | | (500 | ) | | | — | |
Payment of special dividends | | | (47 | ) | | | (179 | ) |
Repurchases of common stock for tax withholding obligations | | | (209 | ) | | | (2,813 | ) |
Proceeds from exercise of stock options, net of cash paid for employee tax withholding | | | 327 | | | | 93 | |
| | | | | | | | |
Net cash used in financing activities | | | (7,246 | ) | | | (5,929 | ) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalent | | | 56 | | | | (243 | ) |
Net increase in cash, cash equivalents and restricted cash equivalent | | | 27,502 | | | | 37,482 | |
Cash, cash equivalents and restricted cash equivalent, at beginning of the period | | | 139,470 | | | | 74,180 | |
| | | | | | | | |
Cash, cash equivalents and restricted cash equivalent, at end of the period | | $ | 166,972 | | | $ | 111,662 | |
| | | | | | | | |
Reconciliation of cash, cash equivalents, and restricted cash equivalent reported in the consolidated balance sheets | | | | | | | | |
Cash and cash equivalents | | $ | 166,972 | | | $ | 86,662 | |
Restricted cash equivalent | | | — | | | | 25,000 | |
| | | | | | | | |
Total cash, cash equivalents, and restricted cash equivalent shown in the condensed consolidated statements of cash flows | | $ | 166,972 | | | $ | 111,662 | |
| | | | | | | | |
Non-cash investing and financing activities | | | | | | | | |
Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities | | $ | 584 | | | $ | 1,282 | |
Change in fair value of hedged interest rate swaps and interest rate cap | | | (3,133 | ) | | | 49 | |
Transfer of interest rate swaps derivative liability to hybrid debt | | | — | | | | 12,345 | |
Deferred offering costs included in accounts payable and accrued expenses and other current liabilities | | | 2,678 | | | | — | |
Deferred financing costs included in accounts payable and accrued expenses and other current liabilities | | | 742 | | | | — | |